Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma

K Sakaizawa, A Ashida, H Uhara… - Clinical Chemistry and …, 2017 - degruyter.com
The advent of therapeutics such as BRAF inhibitors, which are effective against BRAF-
mutated melanoma, has led to great advances in the treatment of metastatic melanoma [1] …
被引用次数：4 相关文章

[引用][C] Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma.

K Sakaizawa, A Ashida, H Uhara… - Clinical Chemistry and …, 2017 - europepmc.org
Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with
metastatic melanoma. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[引用][C] Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma

K Sakaizawa, A Ashida, H Uhara… - Clinical Chemistry and …, 2017 - cir.nii.ac.jp
Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with
metastatic melanoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

[引用][C] Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma

K Sakaizawa, A Ashida, H Uhara… - Clinical chemistry …, 2017 - pubmed.ncbi.nlm.nih.gov
Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with
metastatic melanoma Detection of BRAFV600K mutant tumor-derived DNA in the pleural …

Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma

K Sakaizawa, A Ashida, H Uhara… - Clinical Chemistry and …, 2017 - degruyter.com
The advent of therapeutics such as BRAF inhibitors, which are effective against BRAF-
mutated melanoma, has led to great advances in the treatment of metastatic melanoma [1] …